Out of proportion pulmonary hypertension(PH) in COPD

J. Hurdman, R. Condliffe, C. A. Elliot, R. A. Lawson, C. Billings, I. Armstrong, N. Hamilton, J. Wilkinson, I. Sabroe, D. G. Kiely (Sheffield, United Kingdom)

Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Session: Pulmonary circulation: clinical aspects
Session type: E-Communication Session
Number: 5591
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Hurdman, R. Condliffe, C. A. Elliot, R. A. Lawson, C. Billings, I. Armstrong, N. Hamilton, J. Wilkinson, I. Sabroe, D. G. Kiely (Sheffield, United Kingdom). Out of proportion pulmonary hypertension(PH) in COPD. Eur Respir J 2010; 36: Suppl. 54, 5591

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD) compared with interstitial lung disease (ILD)
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011

Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2008 - Pathophysiology of respiratory diseases
Year: 2008


Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

COPD in farming
Source: Annual Congress 2006 - Farming – a worldwide problem
Year: 2006


To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Airway T-lymphocytes expressing IFN-γ are reduced in smokers with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 6s
Year: 2002

Who are they? Characteristics of smokers with previously undetected COPD
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006


A new multidimensional model for predicting mortality in COPD: body mass index and FEV1 quotient/MRC dyspnoea score (SID)
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006


Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 427s
Year: 2003

Relationship between pulmonary hypertension (PH) and lung function in severe COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 252s
Year: 2001

The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005

Almost half the patients treated for pulmonary tuberculosis (TB) show evidence of obstructive airways disease (OAD)
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007


The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001

Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients?
Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007

The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016